[{"NetIncomeLossConverted_3_Q3_USD":4076900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":911900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":911400000.0,"RevenuesConverted_3_Q3_USD":17099800000.0,"RevenuesConverted_1_Q3_USD":5740600000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.74,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.48,"Assets_0_Q3_USD":43946000000.0,"StockholdersEquity_0_Q3_USD":4826900000.0,"EarningsPerShareDiluted_3_Q3_USD":4.47,"EarningsPerShareDiluted_1_Q3_USD":1.33,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4684400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":907500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":907200000.0,"StockholdersEquityConverted_0_Q3_USD":4996000000.0,"NetIncomeLossConverted_1_Q3_USD":1208400000.0,"EarningsPerShareBasic_1_Q3_USD":1.33,"EarningsPerShareBasic_3_Q3_USD":4.49,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20201028"}]